Overview / Abstract: |
Knowledge of the key management issues for patients with AML is critical Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications. |
Expiration |
Feb 23, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
.25 |
Accreditation |
ACCME, ANCC, ACPE, MOC |
Presenters / Authors / Faculty |
Naval G. Daver, MD Annie Lattanzio Hale, MSN, RN, OCN Megan May, PharmD, BCOP |
Sponsors / Supporters / Grant Providers |
This educational activity is supported by an educational grant from AbbVie. |
Keywords / Search Terms |
American Academy of CME hematology acute myeloid leukemia Free CE CME |